research The Dermatological Spectrum of Coronavirus Disease-19: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
Skin problems like rashes and hair loss can help diagnose and predict COVID-19.
Search
for
Sort by
Research
510-540 / 689 results 
research Cavitating Osmotic Demyelination Syndrome Following Correction of Chronic Hyponatremia in Sheehan’s Syndrome: A Novel Case Report
Careful management of chronic hyponatremia is crucial to prevent severe neurological issues.
research Dermatologic Implications of COVID-19 Infection and Immunization: Hair Loss
Early treatment of COVID-19-related hair loss is crucial for better outcomes.
research Clinical Signs and Laboratory Tests for the Differential Diagnosis of Androgenic and Post-COVID-19 Alopecia in Women
Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.
research Antifungal Activity and Hair Growth Stimulation of Purple Sweet Potato Leaf Fraction (Ipomoea Batatas) and Its Molecular Mechanism Through Androgen Receptor Inhibition
Purple sweet potato leaf extracts can help treat hair loss and fungal infections.
research Efficacy of Dr. SKS Hair Booster Serum for the Treatment of Hair Loss in COVID-19 Induced Persistent Telogen Effluvium
Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.
research The Multisystem Impact of Long COVID: A Comprehensive Review
Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.
research Sex Hormones in COVID-19 Severity: The Quest for Evidence and Influence Mechanisms
Sex hormones may affect COVID-19 severity and outcomes.
research Characteristics of Hair Loss in COVID-19 Patients in Thailand
COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.
research Letter on: Platelet-Rich Plasma for Treatment of Hair Loss Improves Patient-Reported Quality of Life
Platelet-rich plasma treatment for hair loss may improve patients' quality of life.
research Alopecia: An Overall Review Including Causes, COVID-19, Diet, and Treatments
The document concludes that alopecia is an incurable autoimmune disease with various treatments and that diet, as well as COVID-19, may impact it.
research Associations of Telogen Effluvium With Coronavirus Disease 2019 and Research Progress in Its Diagnosis and Treatment
COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.
research The Role of Neurorehabilitation in Post-COVID-19 Syndrome
Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.
research Three Years On, COVID-19 and the Skin: Long-Term Impacts, Emerging Trends and Clinical Practice
COVID-19 can cause long-term skin problems and has changed how skin doctors work.
research Incidence and Probable Risk Factors of Post COVID Syndrome Among COVID-19 Patients in Urban Population of North Kerala: A 6 Months Cohort Study
Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.
research Hormone Replacement Therapy and COVID-19 Outcomes in Solid Organ Transplant Recipients Compared With the General Population
Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.
research Telogen Effluvium Post-COVID: An Integrative Review
COVID-19 can cause temporary hair loss.
research Alopecia and COVID-19: Possible Etiopathogenetic Variants and Therapeutic Approach
COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.
research Acute Telogen Effluvium: A Post-Covid-19 Sequela
COVID-19 infection may cause hair loss.
research A Hair Loss Pandemic: 19 Cases of COVID-19 Induced Telogen Effluvium
COVID-19 can cause hair loss in both severe and mild cases, often affecting women.
research A Systematic Review and Quality Evaluation of Studies on Long-Term Sequelae of COVID-19
COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.
research Telogen Effluvium After COVID-19 Infection: A Case Report
COVID-19 infection may cause hair loss a few months after recovery.
research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
Effective hair regrowth after COVID-19 involves psychological support, good nutrition, and hair growth treatments.
research JAMA Dermatology: The Year in Review, 2021
In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.
research Reporting Cases of Telogen Effluvium as a Sequelae of COVID-19 Infection
COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.
research Hair Loss Associated with COVID-19: Problems and Solutions
COVID-19 can cause temporary hair loss due to stress and inflammation.
research Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.
research COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium: The Role of Proteoglycan Replacement Therapy with Nourkrin in Clinical Treatment of COVID-19 Associated Hair Loss
COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.
research Complementary, Holistic, and Integrative Medicine: Efficacy and Safety in Treating Pediatric Atopic Dermatitis
Some CAM therapies help with pediatric atopic dermatitis, but more research is needed.
research Alopecia in Patients with COVID-19: A Systematic Review and Meta-Analysis
Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.